Norepinephrine
Stress during the fixing process, or may be difficult to demonstrate on section, and no occlusion is seen. [3] [4] [5] [6] Sympathetic catecholamines have been shown to cause platelet aggregation in Vitr07' 9 and to enhance thrombus formation in plastic shunts in vivo.'0 Acute myocardial infarction and sudden death are frequently preceded by severe or prolonged stress." During stress the endogenous secretion of catecholamines is increased.'2 It is possible that stress-induced myocardial infarction is related to the induction by catecholamines of platelet thrombi that form in and occlude narrowed coronary arteries. In order to study the possibility that sympathetic catecholamines can cause intravascular platelet aggregation in the vessels of the heart, we have subjected dogs to prolonged infusions of norepinephrme. It has been known since the early 1900s that PLATELET AGGREGATION INDUCED BY NOREPINEPHRINE catecholamine infusion will result in widespread myocardial necrosis13-23 This necrosis may be due to ischemia resulting from platelet aggregation in small vessels. Previous work in this laboratory has demonstrated that drugs that have an inhibitory effect on platelet aggregation (aspirin and dipyridamole) protect against the necrosis induced by catecholamine infusion.24 25 In the present study using the electron microscope we have sought to demonstrate morphologic evidence of platelet aggregation in the vessels of the heart following catecholamine infusion. Electron micrograph of intramyocardial cavillary after norepinephrine infusion. Note the two well-formed platelets (P) adherent to each other and to the intact vessel wall. See text for discussion.
preseice of myocardial damage (as manifested by myofilament fragmenitation, contraction bands, hyalinization, edema, and degenerative changes of the mitochondria) correlated with the presence of capillaries occluded by platelet thrombus. In contrast, none of the 20 blocks studied for each of the control animals was founid to have capillaries containing aggregated platelets, or myocardial damage. A late thrombus is seen in figure 6 . The wall of the vessel has degenerated and is indistinct with damaged endothelial cells (C) and a large break in vessel-wall continuity at the tips of the arrows. Platelet material and fibrin are extruding through the broken vessel wall (between the two arrows) into the interstitium. The platelets have undergone viscous metamorphosis and degeneration with loss of granules, and with indistinct borders between the platelets. Red cells (R) and a leukocyte (M) Pharmocologic agents that inhibit platelet aggregation or block the effect of catecholamines on platelets might be useful in slowing the progressive course of vascular disease in patients with evidence of early atherosclerosis.
